IGC Pharma Inc (IGC)
0.3768
-0.01
(-2.21%)
USD |
NYAM |
Nov 04, 16:00
0.398
+0.02
(+5.63%)
Pre-Market: 08:48
IGC Pharma Total Assets (Quarterly): 10.59M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 10.59M |
| March 31, 2024 | 9.902M |
| December 31, 2023 | 11.26M |
| September 30, 2023 | 16.51M |
| June 30, 2023 | 15.67M |
| March 31, 2023 | 17.18M |
| December 31, 2022 | 20.07M |
| September 30, 2022 | 21.96M |
| June 30, 2022 | 24.17M |
| March 31, 2022 | 26.83M |
| December 31, 2021 | 31.29M |
| September 30, 2021 | 33.84M |
| June 30, 2021 | 34.44M |
| March 31, 2021 | 35.87M |
| December 31, 2020 | 24.16M |
| September 30, 2020 | 26.35M |
| June 30, 2020 | 28.30M |
| March 31, 2020 | 28.98M |
| December 31, 2019 | 31.10M |
| September 30, 2019 | 32.89M |
| June 30, 2019 | 33.50M |
| March 31, 2019 | 34.46M |
| December 31, 2018 | 37.16M |
| September 30, 2018 | 16.55M |
| June 30, 2018 | 11.52M |
| Date | Value |
|---|---|
| March 31, 2018 | 10.85M |
| December 31, 2017 | 11.34M |
| September 30, 2017 | 9.992M |
| June 30, 2017 | 9.436M |
| March 31, 2017 | 11.28M |
| December 31, 2016 | 11.17M |
| September 30, 2016 | 18.86M |
| June 30, 2016 | 18.50M |
| March 31, 2016 | 18.86M |
| December 31, 2015 | 18.40M |
| September 30, 2015 | 18.82M |
| June 30, 2015 | 20.58M |
| March 31, 2015 | 20.33M |
| December 31, 2014 | 21.26M |
| September 30, 2014 | 21.19M |
| June 30, 2014 | 21.61M |
| March 31, 2014 | 17.73M |
| December 31, 2013 | 18.19M |
| September 30, 2013 | 18.54M |
| June 30, 2013 | 18.58M |
| March 31, 2013 | 19.25M |
| December 31, 2012 | 21.44M |
| September 30, 2012 | 24.22M |
| June 30, 2012 | 24.83M |
| March 31, 2012 | 25.26M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.902M
Minimum
Mar 2024
35.87M
Maximum
Mar 2021
23.60M
Average
24.17M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Protalix BioTherapeutics Inc | 91.54M |
| Palatin Technologies Inc | 10.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.714M |
| Shareholders Equity (Quarterly) | 7.88M |
| Debt to Equity Ratio | 0.0173 |
| Current Ratio | 1.771 |
| Net Debt Paydown Yield | 0.00% |